Your browser doesn't support javascript.
loading
Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment.
Helmy, Sahar A; El-Mofty, Saif; El Gayar, Amal M; El-Sherbiny, Ibrahim M; El-Far, Yousra M.
Afiliación
  • Helmy SA; Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
  • El-Mofty S; Nanomedicine Research Labs, Center for Materials Sciences, Zewail City of Science and Technology, 6th October City, 12578 Giza, Egypt.
  • El Gayar AM; Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
  • El-Sherbiny IM; Nanomedicine Research Labs, Center for Materials Sciences, Zewail City of Science and Technology, 6th October City, 12578 Giza, Egypt. Electronic address: ielsherbiny@zewailcity.edu.eg.
  • El-Far YM; Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt. Electronic address: yousraelfar@mans.edu.eg.
Biomed Pharmacother ; 145: 112376, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34749055
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Doxorrubicina / Nanopartículas / Antibióticos Antineoplásicos Tipo de estudio: Guideline Límite: Animals Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article País de afiliación: Egipto
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Doxorrubicina / Nanopartículas / Antibióticos Antineoplásicos Tipo de estudio: Guideline Límite: Animals Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article País de afiliación: Egipto